Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Epigenetics Market: By Product: Kits, Reagents, Enzymes, Instruments; By Application: Oncology, Non-Oncology; By End Use: Academic and Research Institutes, Others; Regional Analysis; Historical Market and Forecast (2018-2028); Market Dynamics: SWOT Analysis; Competitive Landscape; Industry Events and Developments

Global Epigenetics Market Outlook

The global epigenetics market stood at a value of around USD 877 million in 2020. The market is further expected to grow at a CAGR of 13.6% in the forecast period of 2023-2028 to attain a value of USD 1,908 million by 2026.

 

Global Epigenetics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Kits Segment to Possess a Substantial Share of the Global Epigenetics Industry

Based on product, the kits segment holds a significant share in the global epigenetics industry. This growth can be attributed to the important role of kits in the entire epigenetic analysis process. Furthermore, this number is further expected to rise in the forecast period due to the increasing chronic illnesses and the growing geriatric population rates, which is very susceptible to acquiring various diseases, including cardiovascular diseases or cancer. Meanwhile, the oncology segment is estimated to observe a healthy growth in terms of application due to the high usage of epigenetic research in the oncology field.

 

North America to Account for a Significant Market Share of the Global Epigenetics Industry

North America is predicted to occupy a considerable share of the global epigenetics industry. This surge can be attributed to the increased utilisation of epigenetic research in the region and the increased investments in the development of the healthcare sector. Another factor influencing the market growth is the rising geriatric population in the region, who are susceptible to chronic diseases such as Parkinson’s disease and cancer.

 

Epigenetics: Market Segmentation

Epigenetics is an emerging scientific area of study that analyses how environmental influences impact the expression of genes. Based on different environmental experiences, genes are activated and deactivated by cells without any change in the underlying DNA structure of the organism and predict which proteins are transcribed. These external environmental stimuli can affect the genes, which could influence diseases. In addition, research has indicated that many human diseases occur due to the interaction between genetic variants and environmental exposure, such as autism, Parkinson’s disease, and breast cancer, among others.

 

Global Epigenetics Market by Segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

By product, the market is divided into:

  • Kits
  • Reagents
  • Enzymes
  • Instruments

Kits are further divided by type into ChIP sequencing kits, bisulfite conversion kits, whole genome amplification kits, 5-hmC & 5-mC analysis kits, and RNA sequencing kits, among others. At the same time, reagents are further segmented by type into antibodies, magnetic beads, histones, buffers, primers, and others. Meanwhile, enzymes are categorised by type into DNA polymerases, DNA ligases, methyltransferases, acetylases, and reverse transcriptase, among others. And instruments are segregated by type into next-generation sequencers, qPCRs, mass spectrometers, sonicators, and others.

On the basis of application, the industry can be categorised into:

  • Oncology 
  • Non-Oncology

Oncology is further divided by type into solid tumours and liquid tumours, whereas non-oncology is segmented by type into metabolic diseases, infectious diseases, inflammatory diseases, cardiovascular diseases, and others.

Based on end use, the market can be segmented into:

  • Academics and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organisations

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Global Epigenetics Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Increasing Prevalence of Cardiovascular Diseases to Augment the Growth of the Global Epigenetics Industry

According to WHO reports, cardiovascular diseases are the leading cause of death globally, claiming more than 17.9 million lives every year. Cardiovascular diseases are illnesses of heart and blood vessels that are adversely affected by high-risk behaviours such as unhealthy diet, physical inactivity, and substance abuse. In this regard, epigenetic research has found epigenetic biomarkers, a promising tool for the diagnosis and prognosis of many cardiovascular diseases. Some of their promising features include easy accessibility and feasibility in their detection methods, making them applicable for use in clinical interventions. This is significantly contributing to the growth of the market.

In a 2017 research by the American Diabetes Association, the researchers concluded that diabetes is a complication developed from the interaction of DNA structure variation and the environmental stimuli that causes changes in the cellular phenotype.

 

Key Industry Players in the Global Epigenetics Market

The report gives a detailed analysis of the following key players in the global epigenetics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Abcam Plc
  • Active Motif, Inc.
  • Agilent Technologies, Inc.
  • Diagenode S.A.
  • QIAGEN GmbH
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model and SWOT analysis.

 

REPORT FEATURES DETAILS
Base Year 2022
Historical Period 2018-2022
Forecast Period 2023-2028
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Application, End Use, Region
Breakup by Product Kits, Reagents, Enzymes, Instruments
Breakup by Application Oncology, Non-Oncology
Breakup by End Use Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Contract Research Organisations
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Abcam Plc, Active Motif, Inc., Agilent Technologies, Inc., Diagenode S.A., QIAGEN GmbH, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Opportunities and Challenges in the Market
8    Global Epigenetics Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Epigenetics Historical Market (2018-2022) 
    8.3    Global Epigenetics Market Forecast (2023-2028)
    8.4    Global Epigenetics Market by Product
        8.4.1    Kits
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2018-2022)
            8.4.1.3    Forecast Trend (2023-2028)
            8.4.1.4    Breakup by Type
                8.4.1.4.1    ChIP Sequencing Kits
                8.4.1.4.2    Bisulfite Conversion Kits
                8.4.1.4.3    Whole Genome Amplification Kits
                8.4.1.4.4    5-hmC & 5-mC Analysis Kits
                8.4.1.4.5    RNA Sequencing Kits
                8.4.1.4.6    Others
        8.4.2    Reagents
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2018-2022)
            8.4.2.3    Forecast Trend (2023-2028)
            8.4.2.4    Breakup by Type
                8.4.2.4.1    Antibodies
                8.4.2.4.2    Magnetic Beads 
                8.4.2.4.3    Histones 
                8.4.2.4.4    Buffers
                8.4.2.4.5    Primers
                8.4.2.4.6    Others
        8.4.3    Enzymes
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2018-2022)
            8.4.3.3    Forecast Trend (2023-2028)
            8.4.3.4    Breakup by Type
                8.4.3.4.1    DNA Polymerases
                8.4.3.4.2    DNA Ligases 
                8.4.3.4.3    Methyltransferases
                8.4.3.4.4    Acetylases
                8.4.3.4.5    Reverse Transcriptase
                8.4.3.4.6    Others
        8.4.4    Instruments
            8.4.4.1    Market Share
            8.4.4.2    Historical Trend (2018-2022)
            8.4.4.3    Forecast Trend (2023-2028)
            8.4.4.4    Breakup by Type
                8.4.4.4.1    Next generation sequencers
                8.4.4.4.2    qPCRs
                8.4.4.4.3    Mass Spectrometers
                8.4.4.4.4    Sonicators
                8.4.4.4.5    Others
    8.5    Global Epigenetics Market by Application
        8.5.1    Oncology
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2018-2022)
            8.5.1.3    Forecast Trend (2023-2028)
            8.5.1.4    Breakup by Type
                8.5.1.4.1    Solid Tumors
                8.5.1.4.2    Liquid Tumors
        8.5.2    Non-Oncology
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2018-2022)
            8.5.2.3    Forecast Trend (2023-2028)
            8.5.2.4    Breakup by Type
                8.5.2.4.1    Metabolic Diseases
                8.5.2.4.2    Infectious Diseases
                8.5.2.4.3    Inflammatory Diseases
                8.5.2.4.4    Cardiovascular Diseases
                8.5.2.4.5    Others
    8.6    Global Epigenetics Market by End Use
        8.6.1     Academic and Research Institutes
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2018-2022)
            8.6.1.3    Forecast Trend (2023-2028)
        8.6.2    Pharmaceutical and Biotechnology Companies
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2018-2022)
            8.6.2.3    Forecast Trend (2023-2028)
        8.6.3    Contract Research Organisations
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2018-2022)
            8.6.3.3    Forecast Trend (2023-2028)    
    8.7    Global Epigenetics Market by Region
        8.7.1    North America
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2018-2022) 
            8.7.1.3    Forecast Trend (2023-2028)
        8.7.2    Europe
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2018-2022) 
            8.7.2.3    Forecast Trend (2023-2028)
        8.7.3    Asia Pacific
            8.7.3.1    Market Share
            8.7.3.2    Historical Trend (2018-2022)
            8.7.3.3    Forecast Trend (2023-2028)
        8.7.4    Latin America
            8.7.4.1    Market Share
            8.7.4.2    Historical Trend (2018-2022) 
            8.7.4.3    Forecast Trend (2023-2028)
        8.7.5    Middle East and Africa
            8.7.5.1    Market Share
            8.7.5.2    Historical Trend (2018-2022) 
            8.7.5.3    Forecast Trend (2023-2028)
9    North America Epigenetics Market Analysis
    9.1    United States of America 
        9.1.1    Market Share
        9.1.2    Historical Trend (2018-2022) 
        9.1.3    Forecast Trend (2023-2028)
    9.2    Canada
        9.2.1    Market Share
        9.2.2    Historical Trend (2018-2022) 
        9.2.3    Forecast Trend (2023-2028)
10    Europe Epigenetics Market Analysis
    10.1    United Kingdom
        10.1.1    Market Share
        10.1.2    Historical Trend (2018-2022) 
        10.1.3    Forecast Trend (2023-2028)
    10.2    Germany
        10.2.1    Market Share
        10.2.2    Historical Trend (2018-2022) 
        10.2.3    Forecast Trend (2023-2028)
    10.3    France
        10.3.1    Market Share
        10.3.2    Historical Trend (2018-2022) 
        10.3.3    Forecast Trend (2023-2028)
    10.4    Italy
        10.4.1    Market Share
        10.4.2    Historical Trend (2018-2022) 
        10.4.3    Forecast Trend (2023-2028)
    10.5    Others
11    Asia Pacific Epigenetics Market Analysis
    11.1    China
        11.1.1    Market Share
        11.1.2    Historical Trend (2018-2022) 
        11.1.3    Forecast Trend (2023-2028)
    11.2    Japan
        11.2.1    Market Share
        11.2.2    Historical Trend (2018-2022) 
        11.2.3    Forecast Trend (2023-2028)
    11.3    India
        11.3.1    Market Share
        11.3.2    Historical Trend (2018-2022) 
        11.3.3    Forecast Trend (2023-2028)
    11.4    ASEAN
        11.4.1    Market Share
        11.4.2    Historical Trend (2018-2022) 
        11.4.3    Forecast Trend (2023-2028)
    11.5    Australia
        11.5.1    Market Share
        11.5.2    Historical Trend (2018-2022) 
        11.5.3    Forecast Trend (2023-2028)
    11.6    Others
12    Latin America  Epigenetics Market Analysis
    12.1    Brazil
        12.1.1    Market Share
        12.1.2    Historical Trend (2018-2022) 
        12.1.3    Forecast Trend (2023-2028)
    12.2    Argentina
        12.2.1    Market Share
        12.2.2    Historical Trend (2018-2022) 
        12.2.3    Forecast Trend (2023-2028)
    12.3    Mexico
        12.3.1    Market Share
        12.3.2    Historical Trend (2018-2022) 
        12.3.3    Forecast Trend (2023-2028)
    12.4    Others
13    Middle East and Africa Epigenetics Market Analysis
    13.1    Saudi Arabia
        13.1.1    Market Share
        13.1.2    Historical Trend (2018-2022) 
        13.1.3    Forecast Trend (2023-2028)
    13.2    United Arab Emirates
        13.2.1    Market Share
        13.2.2    Historical Trend (2018-2022) 
        13.2.3    Forecast Trend (2023-2028)
    13.3    Nigeria
        13.3.1    Market Share
        13.3.2    Historical Trend (2018-2022) 
        13.3.3    Forecast Trend (2023-2028)
    13.4    South Africa
        13.4.1    Market Share
        13.4.2    Historical Trend (2018-2022) 
        13.4.3    Forecast Trend (2023-2028)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Competitive Landscape
    15.1    Market Structure
    15.2    Company Profiles
        15.2.1    Abcam Plc
            15.2.1.1    Company Overview
            15.2.1.2    Product Portfolio
            15.2.1.3    Demographic Reach and Achievements
            15.2.1.4    Certifications
        15.2.2    Active Motif, Inc.
            15.2.2.1    Company Overview
            15.2.2.2    Product Portfolio
            15.2.2.3    Demographic Reach and Achievements
            15.2.2.4    Certifications
        15.2.3    Agilent Technologies, Inc.
            15.2.3.1    Company Overview
            15.2.3.2    Product Portfolio
            15.2.3.3    Demographic Reach and Achievements
            15.2.3.4    Certifications
        15.2.4    Diagenode S.A.
            15.2.4.1    Company Overview
            15.2.4.2    Product Portfolio
            15.2.4.3    Demographic Reach and Achievements
            15.2.4.4    Certifications
        15.2.5    QIAGEN GmbH
            15.2.5.1    Company Overview
            15.2.5.2    Product Portfolio
            15.2.5.3    Demographic Reach and Achievements
            15.2.5.4    Certifications
        15.2.6    Others
16    Key Trends and  Developments in the Market

 

List of Key Figures and Tables

1.    Global Epigenetics Market: Key Industry Highlights, 2018 and 2028
2.    Global Epigenetics Historical Market: Breakup by Product (USD Million), 2018-2022
3.    Global Epigenetics Market Forecast: Breakup by Product (USD Million), 2023-2028
4.    Global Epigenetics Historical Market: Breakup by Application (USD Million), 2018-2022
5.    Global Epigenetics Market Forecast: Breakup by Application (USD Million), 2023-2028
6.    Global Epigenetics Historical Market: Breakup by End Use (USD Million), 2018-2022
7.    Global Epigenetics Market Forecast: Breakup by End Use (USD Million), 2023-2028
8.    Global Epigenetics Historical Market: Breakup by Region (USD Million), 2018-2022
9.    Global Epigenetics Market Forecast: Breakup by Region (USD Million), 2023-2028
10.    North America Epigenetics Historical Market: Breakup by Country (USD Million), 2018-2022
11.    North America Epigenetics Market Forecast: Breakup by Country (USD Million), 2023-2028
12.    Europe Epigenetics Historical Market: Breakup by Country (USD Million), 2018-2022
13.    Europe Epigenetics Market Forecast: Breakup by Country (USD Million), 2023-2028
14.    Asia Pacific Epigenetics Historical Market: Breakup by Country (USD Million), 2018-2022
15.    Asia Pacific Epigenetics Market Forecast: Breakup by Country (USD Million), 2023-2028
16.    Latin America Epigenetics Historical Market: Breakup by Country (USD Million), 2018-2022
17.    Latin America Epigenetics Market Forecast: Breakup by Country (USD Million), 2023-2028
18.    Middle East and Africa Epigenetics Historical Market: Breakup by Country (USD Million), 2018-2022
19.    Middle East and Africa Epigenetics Market Forecast: Breakup by Country (USD Million), 2023-2028
20.    Global Epigenetics Market Structure

Key Questions Answered in the Report

In 2020, the  global epigenetics market attained a value of nearly USD 877 million.

The market is projected to grow at a CAGR of 13.6% between 2023 and 2028.

The major drivers of the industry such as increased investment in the research and development of epigenetic interventions, increasing chronic illnesses, increased application of epigenetic analysis mechanisms in the oncology field, and rising ageing population globally are expected to aid the market growth.

The key market trends guiding the industry's growth include the increasing incidences of cardiovascular diseases and increased utilisation of epigenetic research.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The significant product segments can be divided into kits, reagents, enzymes, and instruments.

The significant applications of the product include oncology and non-oncology. The oncology segment is further divided by type into solid tumours and liquid tumours, whereas non-oncology is distributed by type into metabolic disease, infectious diseases, inflammatory diseases, and cardiovascular diseases, among others.

The major segments based on end-use include academics and research institutes, pharmaceutical and biotechnology companies, and contract research organisations.

The major players in the industry are Abcam Plc, Active Motif, Inc., Agilent Technologies, Inc., Diagenode S.A., and QIAGEN GmbH, among others.

Analyst Review

The global epigenetics market attained a value of USD 877 million in 2020, driven by the growing incidences of cardiovascular diseases globally. Aided by the rapidly growing geriatric population and the technological advancements, the market is expected to witness a further growth in the forecast period of 2023-2028, growing at a CAGR of 13.6%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. By products, the market can be distributed into kits, reagents, enzymes, and instruments. On the basis of applications, the industry can be segmented into oncology and non-oncology. Among this oncology is further divided by type into solid tumours and liquid tumours, whereas non-oncology is distributed by type into metabolic disease, infectious diseases, inflammatory diseases, and cardiovascular diseases, among others. Based on end-use, the market can be categorised into academics and research institutes, pharmaceutical and biotechnology companies, and contract research organisations. The major regional markets for epigenetics market are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Abcam Plc, Active Motif, Inc., Agilent Technologies, Inc., Diagenode S.A., and QIAGEN GmbH, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER